One post from Rebekah Leah Campbell's dossier. This page reviews a single piece of material. The full dossier cross-checks 15 materials and carries the verified credential and scope verdicts.
Read the full dossier →https://web.archive.org/web/20260824145848/https://www.youtube.com/watch?v=sMUkYPArq0A
View dossier →Rebekah Leah Campbell alias The Mold Bucket Maven
YouTube · UCMV5JjJ-tR24TFABiuPCOtg
Practice location
821 E OCEAN BLVD
STUART, FL 34994
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 13 health claims, 9 run counter to or conflict with the published evidence, and 2 were not independently checked.
- Primary persuasion tactic: The hidden toxin villain.
- Stated credentials look inflated relative to the advice given.
- Gives advice beyond what their license covers.
Becky Campbell serves the classic doc-bro sampler platter: normal labs become proof of a hidden mold villain, histamine gets a cute bucket metaphor, and every vague reaction is invited into the same storyline. Then the audience is handed a quiz and a funnel-hosted guide, because apparently the bucket also collects email addresses.
High grift signals
Score breakdown
Direct answer
Rebekah Leah Campbell is licensed in Florida as a chiropractor (DC), not as an MD or DO, and Florida's chiropractic scope statute (Fla. Stat. § 460.403(9)(b), (f)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Mold illness, Mast cell activation syndrome, Perimenopause histamine flare-up, Estrogen dominance and histamine, and Cleanest Retail Picks for MCAS, conditions that belong with endocrinologists and allergy and immunology specialists.
Key findings
- Fear Mongering: The framing suggests an unseen environmental toxin is the real explanation for diffuse symptoms, which can encourage anxious self-diagnosis without establishing exposure or clinical causation.see section ↓
- Claim "People who react to many foods, perfume, supplements, weather changes, or wine are direct…": only partially supported.see section ↓
- Claim "The video promises an exact step-by-step order of operations for feeling better, includin…": not supported by peer-reviewed evidence.see section ↓
- NPI registry confirms Becky Campbell as Chiropractor (DC) in Florida (NPI 1124284260).see section ↓
- Rebekah Leah Campbell shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Rebekah Leah Campbell is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Florida Board of Chiropractic Medicine scope rules (Fla. Stat. § 460.403(9)(b), (f)), these advertised activities appear outside Rebekah Leah Campbell's license (including conditions they merely list as ones they treat): Hidden toxic mold and mycotoxins are presented as a driver of…see section ↓
- 16 of 16 advertised activities fall outside permitted Chiropractor scope in FL.see section ↓
Claims & evidence
12 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to advertise Hidden toxic mold and mycotoxins are presented as a driver of histamine intolerance, MCAS, and broad unexplained symptoms. as within their scope of practice.
Hidden toxic mold and mycotoxins are presented as a driver of histamine intolerance, MCAS, and broad unexplained symptoms.
- Supports
- Indoor dampness and mold exposure are associated with respiratory symptoms, allergies, asthma exacerbation, and certain hypersensitivity conditions, so mold can contribute to some symptoms in susceptible people. [1][2][3][5][6][7] However, this does not establish hidden mycotoxins as a driver of histamine intolerance or MCAS. Experimental research reports that fungi can activate mast cells and inflammatory pathways, but this is mechanistic evidence rather than proof that indoor mold causes clinical MCAS or broad unexplained illness. [4]
- Contradicts
- The WHO evidence review states that evidence for mycotoxins causing health problems from indoor air is extremely weak, despite stronger evidence for dampness and mold being associated with respiratory disease. [1][2][3][5][6][7][8] A critical review found no compelling evidence that mycotoxin exposure at levels expected in most mold-contaminated indoor environments produces measurable human health effects. A later review likewise concluded that there is no established causative relationship between indoor mold and the broad symptom syndromes often attributed to it, and that mycotoxins are not established allergens. Consensus criteria for MCAS require recurrent systemic mast-cell activation symptoms, objective mediator elevation, and response to mast-cell-directed treatment; environmental mold exposure is not a diagnostic criterion or established general cause. [4] The supplied index results are FDA recall notices rather than peer-reviewed clinical evidence and do not support this claim.
- Mainstream view
- Damp or moldy buildings should be corrected because they can increase risks of respiratory symptoms, asthma, allergy, and uncommon hypersensitivity disorders. [3][4] The mainstream medical position does not recognize hidden mold or indoor mycotoxins as an established explanation for histamine intolerance, MCAS, or broad unexplained symptoms. [1][2][5][6][7][8] Such symptoms require standard clinical assessment and consideration of alternative diagnoses; mold or mycotoxin testing is not routinely recommended as a diagnostic explanation.
“The Hidden Driver: Mold & Mycotoxins”
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure An estrogen and perimenopause histamine loop is presented as an explanation for histamine flares..
An estrogen and perimenopause histamine loop is presented as an explanation for histamine flares.
- Supports
- Estrogen can modulate mast-cell number and histamine release in experimental models, and human basophil experiments found that estrogen enhanced IgE-mediated histamine release, supporting biological plausibility for hormone-sensitive histamine symptoms . [11][13] Sex hormones can alter mast-cell degranulation in a dose-, sex-, and stimulus-dependent manner, although much of this evidence is experimental rather than clinical . [10][12] Perimenopause involves substantial fluctuation in estrogen production, providing a plausible hormonal context for symptom variability .
- Contradicts
- The listed index papers do not directly study an estrogen–perimenopause–histamine feedback loop or establish that it explains histamine flares; most are unrelated clinical-trial records . [12] Evidence is inconsistent regarding the direction of estrogen's effects: experimental findings include enhancement, inhibition, or no effect depending on cell type and stimulus. [10][13] A review of histamine intolerance discusses menstrual-cycle associations and estrogen-related histamine metabolites, but does not validate a perimenopausal causal loop or establish diagnostic or treatment implications . Direct high-quality human studies linking perimenopausal hormone fluctuations to recurrent histamine flares are lacking, and no major guideline presents this loop as an established explanation. [11]
- Mainstream view
- The mainstream view is that estrogen and other sex hormones can influence mast cells, basophils, vascular responses, and possibly histamine metabolism, so hormone-related modulation of allergic or histamine-mediated symptoms is biologically plausible. [10][11][13] However, an estrogen–perimenopause histamine loop remains a proposed mechanism, not a clinically established general explanation for histamine flares. Symptoms require assessment for defined conditions such as urticaria, allergy, mast-cell disorders, medication effects, or other causes rather than attribution to this loop alone.
“The Estrogen & Perimenopause Histamine Loop”
Rule: Fla. Stat. § 460.403(9)(b), (f)
See every doc bro advertising Hormone imbalance and replacement
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure Mold illness.
Mold illness
- Supports
- Mold and damp indoor environments are associated with respiratory and allergic conditions such as asthma, rhinitis, respiratory infections, and hypersensitivity pneumonitis, and remediation can reduce some asthma-related symptoms. [1][18][2][5] However, this supports evaluation and treatment of specific recognized conditions, not a generic licensed treatment for “mold illness. ” None of the listed index papers directly evaluates mold illness or its treatment.
- Contradicts
- “Licensed treatment of Mold illness” is not a sufficiently defined medical intervention or established diagnosis. Major evidence reviews describe health effects from dampness and mold but do not validate a single nonspecific mold-illness syndrome, universal mold-toxin testing, or a standardized treatment protocol. Indoor mold measurements and blood or urine tests for mold components are generally not recommended for routine medical evaluation, and individual symptoms cannot reliably be attributed to a particular mold exposure. [1][18][2][5] The listed index records concern unrelated clinical trials and provide no supporting evidence.
- Mainstream view
- Mainstream medicine recognizes that damp or moldy environments can worsen or cause specific respiratory, allergic, and occasionally infectious diseases. Recommended management is exposure reduction or remediation, standard diagnostic evaluation, and evidence-based treatment of the identified condition. A broad, standalone “mold illness” diagnosis and a generally accepted licensed treatment protocol are not established. [1][18][2][5]
“Mold illness”
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure Mast cell activation syndrome.
Mast cell activation syndrome
- Supports
- There are established clinical treatments used to manage MCAS symptoms, including trigger avoidance, H1 and H2 antihistamines, leukotriene modifiers, cromolyn, and, in selected refractory cases, omalizumab. [19][21] These treatments are generally directed at controlling mediator-related symptoms rather than curing MCAS.
- Contradicts
- The indexed papers are unrelated clinical-trial records and provide no evidence that any treatment is licensed specifically for MCAS. [19][20][21] The academic evidence indicates that there are no FDA-approved medications specifically for MCAS; commonly used drugs are approved for other conditions and may be used off-label. Evidence for MCAS-specific therapies is largely based on consensus, observational data, extrapolation, and symptom response rather than robust randomized trials. Omalizumab and other agents may be licensed for conditions such as asthma, urticaria, or systemic mastocytosis, but that does not constitute licensing for MCAS.
- Mainstream view
- MCAS should be diagnosed using accepted clinical, laboratory, and response-to-treatment criteria and managed individually by clinicians familiar with mast-cell disorders. [19][20][21][22] Acute anaphylaxis requires intramuscular epinephrine, while ongoing symptom control commonly uses antihistamines and other mediator-targeted drugs. No medication is generally licensed specifically to treat MCAS, and treatment claims should distinguish licensed indications from off-label use.
“Mast Cell Activation Syndrome (MCAS)”
Rule: Fla. Stat. § 460.403(9)(b), (f)
See every doc bro advertising MCAS and histamine intolerance
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure Perimenopause histamine flare-up.
Perimenopause histamine flare-up
- Supports
- Licensed treatments exist for menopausal symptoms such as hot flashes, including menopausal hormone therapy and selected nonhormonal medicines, but the supplied index papers do not address perimenopause-related histamine flare-ups. [23][25] The review evidence describes antihistamine treatment for histamine intolerance as empirical and notes that randomized clinical trials demonstrating efficacy are lacking. [24][12] The available evidence also indicates that suspected histamine intolerance is frequently not confirmed by blinded provocation testing.
- Contradicts
- The claim is too nonspecific to establish what treatment, diagnosis, or outcome is meant. Major menopause guidance focuses on vasomotor, genitourinary, mood, sleep, and bleeding symptoms rather than recognizing a defined licensed treatment indication called a perimenopause histamine flare-up. [23] Evidence connecting perimenopause to histamine or mast-cell symptoms is mechanistic or observational, and evidence for antihistamines, low-histamine diets, or DAO supplements specifically treating perimenopausal flares is insufficient. [25] None of the supplied index studies evaluates this claim: the listed trials concern glycemic monitoring, rheumatoid-arthritis exercise, angioplasty, medical education, heart failure devices, rural mHealth, training, or neck-pain therapy. The histamine-intolerance review states that antihistamine therapy is empirical and that randomized trials proving benefit are absent. [24] A placebo-controlled histamine-challenge study found that histamine intolerance was excluded in 84. 7% of participants, highlighting diagnostic uncertainty.
- Mainstream view
- Clinicians should assess the actual symptoms and rule out allergy, chronic urticaria, mast-cell disorders, medication effects, thyroid disease, and other causes rather than assume a perimenopausal histamine flare-up. [24][25] Evidence-based treatment should target the confirmed condition; standard perimenopause treatments such as hormone therapy or nonhormonal therapy are used for guideline-recognized menopausal symptoms, not for an established histamine-flare diagnosis. [23][12] Antihistamines or dietary measures may be considered selectively under clinical supervision, but no broadly accepted licensed treatment specifically for perimenopause-related histamine flare-ups is established.
“perimenopause histamine flare up”
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to advertise Estrogen dominance and histamine as within their scope of practice.
Estrogen dominance and histamine
- Supports
- Licensed treatments exist for specific, medically defined estrogen-related conditions and histamine-mediated disorders, but not for the combined label "estrogen dominance and histamine. [24][34] " Histamine-related conditions such as urticaria and mast-cell activation disorders may be treated with clinician-directed H1 antihistamines, sometimes H2 blockers or other therapies. [35][36] The index paper on unusual urticarias addresses recognized urticaria disorders and their clinical management . [26][29] The index paper on primary atopic disorders concerns diagnostic identification of defined allergic disease rather than a general estrogen–histamine syndrome . [27][33]
- Contradicts
- "Estrogen dominance" is not a standardized diagnosis with a universally accepted biomarker, and the claim does not specify a disease, diagnostic criteria, treatment, or outcome. Evidence that estrogen can influence immune or mast-cell biology does not establish a licensed treatment for a condition called estrogen dominance, nor does it show that treating estrogen dominance treats histamine symptoms. [35][36] Histamine intolerance itself has uncertain diagnostic validity, lacks a validated biomarker, and antihistamine treatment is largely empirical; a review notes that randomized clinical trials demonstrating antihistamine benefit in histamine intolerance are lacking. [24][34] The index paper on postprandial symptoms concerns disorders of gut-brain interaction and does not validate estrogen dominance or a histamine syndrome . [26] The index paper on a botanical supplement is an open-label study and does not establish licensed treatment of either claimed condition . [30] The remaining index papers concern insomnia, stress-ulcer prophylaxis, tumor immunology, and STAT3 hyper-IgE syndrome, and do not directly support this claim . [28][31][33]
- Mainstream view
- Mainstream medicine evaluates abnormal estrogen states by specific clinical context and validated testing, such as menopause, hypogonadism, endocrine disease, or estrogen-producing tumors, rather than diagnosing a nonspecific "estrogen dominance" syndrome. [33] Histamine symptoms are evaluated for established causes including allergy, urticaria, mast-cell disorders, medication effects, and gastrointestinal disease. [26][35][36] Treatment is directed at the confirmed condition; antihistamines are established for appropriate allergic and urticarial disorders, while treatment of presumed histamine intolerance is individualized and evidence is limited. [24][34] No mainstream guideline recognizes a single licensed treatment for "estrogen dominance and histamine" as stated.
“estrogen dominance and histamine”
Rule: Fla. Stat. § 460.403(9)(b), (f)
See every doc bro advertising Hormone imbalance and replacement
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to advertise Cleanest Retail Picks for MCAS as within their scope of practice.
Cleanest Retail Picks for MCAS
- Supports
- No high-quality evidence supports a licensed treatment category called "Cleanest Retail Picks" for MCAS. [37][20] The literature describes management using trigger avoidance and clinician-directed antimediator therapies such as antihistamines, cromolyn, leukotriene modifiers, and, in selected cases, other medicines; it does not validate retail product rankings or a licensed treatment under this name. [39][40][42][19][45] The AAAAI work-group report addresses diagnosis and treatment of MCAS but does not establish "Cleanest Retail Picks" as a treatment. [41][22]
- Contradicts
- The claim is not meaningfully addressed by the listed index papers: the papers concern genetic medicines, chiropractic, buprenorphine programs, diabetes and driving, HPV vaccines, monoclonal antibodies, preventive medicine, and Parkinson disease driving, rather than MCAS retail products or licensed treatment. [37][38][39][40][41][42][43][44][19][45] There is no demonstrated clinical evidence that selecting products marketed as the "cleanest" treats MCAS, and the available review literature notes that there was no official treatment guideline for MCAS at the time of publication. [20]
- Mainstream view
- MCAS requires careful confirmation using accepted clinical, laboratory, and response-to-therapy criteria, followed by individualized medical management. [40][19] Usual approaches include identifying and avoiding confirmed triggers, antihistamines and other mediator-directed medicines, and emergency epinephrine when anaphylaxis occurs; product purity or retail marketing labels are not recognized as licensed MCAS treatment. [37][39][42][20]
“Cleanest Retail Picks for MCAS”
Rule: Fla. Stat. § 460.403(9)(c)1.
See every doc bro advertising MCAS and histamine intolerance
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure The Perimenopause and Histamine Guide.
The Perimenopause and Histamine Guide
No specific health claims of theirs were cross-checked against the literature.
“The Perimenopause and Histamine Guide”
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure Perimenopause and Histamine Quiz.
Perimenopause and Histamine Quiz
No specific health claims of theirs were cross-checked against the literature.
“Perimenopause and Histamine Quiz”
Rebekah Leah Campbell is not approved to offer The video promises an exact step-by-step order of operations for feeling better, including an implied mold-detox approach. within a Chiropractor scope of practice under Florida Board of Chiropractic Medicine.
The video promises an exact step-by-step order of operations for feeling better, including an implied mold-detox approach.
- Supports
- The claim accurately describes the video's apparent promise, but the listed index papers do not provide direct evidence that an exact step-by-step order of operations improves health or that a mold-detox protocol is effective. [46] Evidence-based guidance supports removing or remediating dampness and mold, reducing ongoing exposure, and evaluating symptoms appropriately, not a generalized detox sequence. The WHO guidelines recommend preventing or remediating dampness and mold because exposure is associated with respiratory symptoms, allergies, and asthma . [1][2][47]
- Contradicts
- The index papers are primarily about semaglutide, systematic-review methods, and metaphor analysis, so they do not substantiate a mold-detox protocol. A review advocating nutritional and detoxification strategies exists, but it is not a high-quality randomized trial or major clinical guideline and does not establish an exact sequence or effectiveness of detox interventions. [1][2][47] Clinical guidance indicates that mold-related care should focus on exposure elimination or remediation and standard evaluation of symptoms; routine testing for mold metabolites and broad detoxification approaches are not generally supported. The CDC recommends cleaning up mold and fixing moisture problems, not detoxifying the body. [46]
- Mainstream view
- The mainstream medical position is that indoor dampness and mold can contribute to allergic, irritant, respiratory, and—in susceptible people—infectious or hypersensitivity conditions. [46][1][2][47] Management is individualized and centers on correcting moisture problems, remediating or avoiding contaminated environments, and treating confirmed conditions such as asthma, allergy, sinus disease, or infection. There is no established, evidence-based universal step-by-step mold-detox protocol, and promises of an exact sequence for feeling better should be regarded skeptically.
“the exact step-by-step order of operations to start feeling safe in your body again”
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure Histamine intolerance.
Histamine intolerance
- Supports
- Indoor dampness and mold exposure are associated with respiratory symptoms, allergies, asthma exacerbation, and certain hypersensitivity conditions, so mold can contribute to some symptoms in susceptible people. [1][2][3][5][6][7] However, this does not establish hidden mycotoxins as a driver of histamine intolerance or MCAS. Experimental research reports that fungi can activate mast cells and inflammatory pathways, but this is mechanistic evidence rather than proof that indoor mold causes clinical MCAS or broad unexplained illness. [4]
- Contradicts
- The WHO evidence review states that evidence for mycotoxins causing health problems from indoor air is extremely weak, despite stronger evidence for dampness and mold being associated with respiratory disease. [1][2][3][5][6][7][8] A critical review found no compelling evidence that mycotoxin exposure at levels expected in most mold-contaminated indoor environments produces measurable human health effects. A later review likewise concluded that there is no established causative relationship between indoor mold and the broad symptom syndromes often attributed to it, and that mycotoxins are not established allergens. Consensus criteria for MCAS require recurrent systemic mast-cell activation symptoms, objective mediator elevation, and response to mast-cell-directed treatment; environmental mold exposure is not a diagnostic criterion or established general cause. [4] The supplied index results are FDA recall notices rather than peer-reviewed clinical evidence and do not support this claim.
- Mainstream view
- Damp or moldy buildings should be corrected because they can increase risks of respiratory symptoms, asthma, allergy, and uncommon hypersensitivity disorders. [3][4] The mainstream medical position does not recognize hidden mold or indoor mycotoxins as an established explanation for histamine intolerance, MCAS, or broad unexplained symptoms. [1][2][5][6][7][8] Such symptoms require standard clinical assessment and consideration of alternative diagnoses; mold or mycotoxin testing is not routinely recommended as a diagnostic explanation.
“Histamine Intolerance”
Rule: Fla. Stat. § 460.403(9)(b), (f)
See every doc bro advertising MCAS and histamine intolerance
Rebekah Leah Campbell is not licensed or approved by Florida Board of Chiropractic Medicine to diagnose, treat, or cure Mycotoxin illness.
Mycotoxin illness
- Supports
- Licensed medical care can evaluate and treat specific, recognized conditions associated with mold or mycotoxin exposure, such as asthma, allergic fungal disease, chronic rhinosinusitis, or hypersensitivity pneumonitis. WHO recommends preventing or remediating dampness and mold because exposure is associated with respiratory and allergic health effects. [48][18][2][5] None of the supplied index records evaluates licensed treatment of a condition called mycotoxin illness.
- Contradicts
- The claim is not a specific, established treatment intervention or outcome, and the supplied index records concern unrelated clinical trials rather than mycotoxin illness or its treatment. WHO states that relationships between dampness, microbial exposure, and health effects cannot be quantified precisely and does not establish a general diagnosis or treatment protocol for 'mycotoxin illness. [48][18][2][5] ' CDC materials caution against using unvalidated urine mycotoxin tests to clinically diagnose illness. A review advocating recognition and management from a functional-medicine perspective is not a systematic review, meta-analysis, randomized trial, or major clinical guideline and does not establish efficacy of a licensed treatment.
- Mainstream view
- Licensed clinicians should diagnose and treat well-defined conditions using standard medical criteria, while addressing confirmed dampness or mold exposure through remediation. [48][18][2][5] 'Mycotoxin illness' as a broad diagnosis lacks established consensus diagnostic criteria and validated, evidence-based treatment; individualized evaluation is appropriate when symptoms are present.
“mycotoxin illness”
Manipulation
transcript · cited
The framing suggests an unseen environmental toxin is the real explanation for diffuse symptoms, which can encourage anxious self-diagnosis without establishing exposure or clinical causation. Likely motive: Create fear and curiosity that direct viewers toward the mold quiz, guide, and potentially paid services or products.
“The Hidden Driver: Mold & Mycotoxins”
transcript · cited
This pits conventional clinicians against a hidden explanation and implies that normal testing is evidence that the influencer's framework is more insightful, rather than a reason to reassess the diagnosis carefully. Likely motive: Increase trust in the influencer's root-cause narrative and weaken confidence in ordinary medical evaluation.
“while your doctor insists your labs are "normal"”
transcript · cited
The bucket theory is a simplified explanatory metaphor, not by itself a validated diagnostic model for people reacting to many unrelated triggers or for attributing symptoms to mold. Likely motive: Make a complex, uncertain area feel mechanistically settled and actionable.
“histamine bucket fills up”
transcript · cited
A condition-focused quiz can function as a lead-generation step, turning nonspecific symptoms into a mold-illness identity and collecting prospective customers for later offers. Likely motive: Move viewers from emotionally validating content into an owned marketing funnel.
“Take my Mold Quiz: https://drbeckycampbell.com/moldquiz/”
transcript · cited
The free guide is hosted through a ClickFunnels link, a platform commonly used for email capture and upsells. The clip does not show the downstream offer structure or disclose whether products or services are promoted after signup. Likely motive: Build an email list that can later be monetized through supplements, courses, consultations, or programs.
“Grab my FREE Histamine Guide: https://drbeckycampbell22.clickfunnel...”
transcript · cited
The supplied title and description contain no explicit #ad, affiliate, sponsored, or paid-partnership disclosure. The links may be lead-generation or commercial assets, but the material connection is not explained on this content surface. Likely motive: Preserve the appearance of neutral education while routing viewers into monetizable owned properties.
“Take my Mold Quiz: https://drbeckycampbell.com/moldquiz/”
Commerce & grift map
The visible funnel is symptom-validation content leading to a mold quiz and a ClickFunnels-hosted free histamine guide. No supplement brand, lab panel, affiliate commission, or referral payment is identified in the supplied material, so the downstream money flow remains unverified rather than absent.
No FTC-style compensation disclosure
compensationDisclosures · scan
Host self-funnel around guest content
guestCollaboration · selfFunnel
Host routes viewers to their own consult/booking links around the guest segment.
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Learn: Is a chiropractor a medical doctor?
Credentials and scope reflect the dossier-wide determination for this subject, drawn from the strongest verified material across every analyzed source.
Stated: none · Likely: Chiropractor
Verified against the federal provider registry: DC · Chiropractor · FL license CH9852.
The page uses the title “Becky” but does not state an MD, DO, Chiropractor, ND, or other degree or license for Becky Campbell. Because the title is paired with broad diagnosis and treatment marketing, the credential basis and professional scope are not verifiable from this content.
- Chiropractor (DC), Doctor of Chiropractic
The page uses the title “Becky” but does not state an MD, DO, DC, ND, or other degree or license for Becky Campbell. Because the title is paired with broad diagnosis and treatment marketing, the credential basis and professional scope are not verifiable from this content.
Chiropractic scope is generally limited to evaluation and treatment of musculoskeletal and nervous-system conditions through spinal adjustment and authorized adjunctive therapies, not general internal medicine, prescription pharmacology, or primary disease management.
Permitted scope vs advertised
Florida Board of Chiropractic Medicine · Confidence: high
Florida law authorizes chiropractic physicians to examine, analyze, and diagnose the human body and its diseases using specified physical, chemical, electrical, thermal, X-ray, phlebotomy, and other general examination methods taught in chiropractic schools. It authorizes treatment primarily through chiropractic adjustment or manipulation and specified manual, mechanical, electrical, natural, physiotherapeutic, acupuncture, dry-needling, food, food-concentrate, food-extract, and nonprescription-item methods, while prohibiting legend-drug prescribing or administration except for limited emergency medications, surgery except as expressly stated, and obstetrics.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
- Telehealth practice within chiropractic medicine
16 of 16 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Hidden toxic mold and mycotoxins are presented as a driver of histamine intolerance, MCAS, and broad unexplained symptoms. This presents systemic toxicological and immunologic disease causation rather than diagnosis of abnormal bodily functions within the specifically authorized chiropractic framework. | Outside scope |
| An estrogen and perimenopause histamine loop is presented as an explanation for histamine flares. This is a systemic endocrine and immunologic disease explanation, not an expressly authorized chiropractic diagnosis of abnormal bodily function or nerve-impulse-related dysfunction. | Outside scope |
| People who react to many foods, perfume, supplements, weather changes, or wine are directed toward histamine intolerance or MCAS as an explanation despite normal laboratory results. Directing people to systemic mast-cell or histamine diagnoses is not affirmatively authorized as chiropractic diagnosis under Florida's defined scope. | Outside scope |
| Listed service Mold illness Diagnosing mold illness is a systemic environmental and medical disease diagnosis not expressly authorized by Florida's chiropractic scope statute. | Outside scope |
| Listed service Mast cell activation syndrome Diagnosing MCAS is a systemic immunologic diagnosis and is not affirmatively permitted as a chiropractic diagnosis under the cited scope language. | Outside scope |
| Listed service Perimenopause histamine flare-up This labels a systemic reproductive-endocrine and immunologic condition rather than an expressly authorized chiropractic condition. | Outside scope |
| Listed service Estrogen dominance and histamine This is an endocrine and immune-system disease framework, not an expressly authorized chiropractic diagnosis or treatment target. | Outside scope |
| Listed service Cleanest Retail Picks for MCAS Recommending retail products as treatment for MCAS is treatment of a systemic immunologic disease and is not affirmatively authorized by the chiropractic scope statute. | Outside scope |
| Listed service The Perimenopause and Histamine Guide A guide centered on managing perimenopause and histamine implies systemic endocrine and immunologic health management not affirmatively authorized for chiropractors. | Outside scope |
| Listed service Perimenopause and Histamine Quiz A quiz directing users toward perimenopause or histamine diagnoses is not an expressly authorized chiropractic examination or diagnostic method for those systemic conditions. | Outside scope |
| The video promises an exact step-by-step order of operations for feeling better, including an implied mold-detox approach. An implied mold-detox protocol treats presumed systemic toxic exposure and is not one of Florida's expressly listed chiropractic treatment methods. | Outside scope |
| Listed service Histamine intolerance Diagnosing histamine intolerance is a systemic metabolic or immunologic diagnosis not affirmatively authorized by the chiropractic scope statute. | Outside scope |
| Listed service Mycotoxin illness Diagnosing mycotoxin illness is a systemic toxicologic disease diagnosis outside the statute's expressly defined chiropractic diagnostic and treatment framework. | Outside scope |
| Mold-illness and mycotoxin framework for broad symptoms Using mold illness and mycotoxins to explain broad symptoms is systemic disease attribution rather than an affirmatively authorized chiropractic diagnosis. | Outside scope |
| Mold quiz A quiz aimed at identifying mold illness or mycotoxin disease is not an expressly authorized chiropractic diagnostic method or condition. | Outside scope |
| Order-of-operations approach for histamine and mold symptoms A treatment sequence for histamine and mold symptoms addresses systemic immunologic and toxicologic conditions rather than an expressly authorized chiropractic treatment method. | Outside scope |
Sources: Florida Statutes § 460.403 — Definitions (official), Florida Board of Chiropractic Medicine — Resources (official), Florida Administrative Code Rule 64B2-17.002 — Unauthorized Practice, The 2026 Florida Statutes (official)
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drbeckycampbell.com)
- Linked entityLinked commerce or practice (drbeckycampbell22.clickfunnel)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission Y_wshTwDks58lauFwZ5Qc
Fight disinformation
Log a public thread where Rebekah Leah Campbell is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Rebekah Leah Campbell's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/Y_wshTwDks58lauFwZ5Qc. White-coat charisma isn't evidence.
Full DTMB scan on Rebekah Leah Campbell: https://drtrustmebro.com/analyze/Y_wshTwDks58lauFwZ5Qc
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Rebekah Leah Campbell. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Rebekah Leah Campbell, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Rebekah Leah Campbell. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: HXypsOMo--5cEzxuHpuaZ
- Wall entry: /influencer/HXypsOMo--5cEzxuHpuaZ
- Analysis ID: Y_wshTwDks58lauFwZ5Qc
- Source: https://www.youtube.com/watch?v=sMUkYPArq0A
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] WHO guidelines for indoor air quality : dampness and mould
- [2] WHO guidelines for indoor air quality: dampness and mould
- [3] Health effects associated with dampness and mould
- [4] Chemical Intolerance and Mast Cell Activation - PMC - NIH
- [5] WHO Guidelines for Indoor Air Quality: Dampness and Mould
- [6] Mold, Mycotoxins and a Dysregulated Immune System - PMC - NIH
- [7] Health effects of mycotoxins in indoor air: a critical review - PubMed
- [8] Questions On The Article In...
- [9] Executive Summary
- [10] Women hormones and hypersensitivity: allergic diseases in ... - PMC
- [11] Modulation of rat peritoneal mast cell and human basophil histamine ...
- [12] European Society of Endocrinology clinical practice guideline ...
- [13] Effect of oestradiol on mast cell number and histamine level in the ...
- [14] Mast cell activation syndrome: An up-to-date review of literature
- [15] Histamine Intolerance: Symptoms, Diagnosis, and Beyond
- [16] Mast cell activation syndromes - evaluation of current diagnostic ...
- [17] Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach - PubMed
- [18] WHO guidelines for indoor air quality: dampness and mould: executive summary
- [19] Diagnosis and management of mast cell activation syndrome ... - PMC
- [20] Pharmacological treatment options for mast cell activation disease
- [21] Mast cell activation syndrome: Current understanding and ...
- [22] AAAAI Mast Cell Disorders Committee Work Group Report - PubMed
- [23] Guidelines for Management of Menopause 2010
- [24] Histamine Intolerance—The More We Know the Less ... - PMC - NIH
- [25] The mast cell and histamine concentration of the human post-menopausal uterus - PubMed
- [26] Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target.
- [27] Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.
- [28] Pharmacotherapy of Insomnia.
- [29] Unusual urticarias.
- [30] An Oral Botanical Supplement Improves Small Intestinal Bacterial Overgrowth (SIBO) and Facial Redness: Results of an Open-Label Clinical Study.
- [31] Stress Ulcer Prophylaxis.
- [32] Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice.
- [33] STAT3 Hyper IgE Syndrome.
- [34] Food Intolerance: The Role of Histamine - PMC
- [35] Recent advances in our understanding of mast cell activation - PMC
- [36] An update on mast cell disorders - PMC - NIH
- [37] A roadmap for affordable genetic medicines.
- [38] Chiropractic.
- [39] Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.
- [40] Diabetes and driving.
- [41] Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
- [42] Licensed monoclonal antibodies and associated challenges.
- [43] Do preventive medicine physicians practice medicine?
- [44] [Driving ability in Parkinson's disease].
- [45] Progress in mast cell activation syndrome: the global consensus-2 ...
- [46] Mold - CDC
- [47] [PDF] who guidelines for indoor air quality – dampness and mould - IRIS
- [48] WHO guidelines for indoor air quality: dampness and mould